MoonLake Immunotherapeutics annual net debt
2021
2022
2023
2024
2025
MoonLake Immunotherapeutics Net Debt Growth & History (MLTX)
MoonLake Immunotherapeutics's net debt was −$258.8M for fiscal 2025.
View full MoonLake Immunotherapeutics company overviewMoonLake Immunotherapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$258.8M | −$81.2M | — |
| 2024 | 2024-12-31 | −$177.6M | $269.9M | — |
| 2023 | 2023-12-31 | −$447.5M | −$408.2M | — |
| 2022 | 2022-12-31 | −$39.2M | −$46.2M | — |
| 2021 | 2021-12-31 | $7.0M | — | — |
MoonLake Immunotherapeutics quarterly net debt
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$376.4M | −$145.5M | — |
| Q1 2026 | 2026-03-31 | −$197.7M | −$1.7M | — |
| Q4 2025 | 2025-12-31 | −$258.8M | −$81.2M | — |
| Q3 2025 | 2025-09-30 | −$275.0M | $97.3M | — |
| Q2 2025 | 2025-06-30 | −$230.9M | $108.5M | — |
| Q1 2025 | 2025-03-31 | −$196.0M | $258.8M | — |
| Q4 2024 | 2024-12-31 | −$177.6M | $269.9M | — |
| Q3 2024 | 2024-09-30 | −$372.3M | −$54.3M | — |
| Q2 2024 | 2024-06-30 | −$339.4M | $162.1M | — |
| Q1 2024 | 2024-03-31 | −$454.8M | −$404.9M | — |
| Q4 2023 | 2023-12-31 | −$447.5M | −$408.2M | — |
| Q3 2023 | 2023-09-30 | −$318.0M | −$276.8M | — |
| Q2 2023 | 2023-06-30 | −$501.6M | −$408.9M | — |
| Q1 2023 | 2023-03-31 | −$49.9M | — | — |
| Q4 2022 | 2022-12-31 | −$39.2M | −$46.2M | — |
| Q3 2022 | 2022-09-30 | −$41.2M | — | — |
| Q2 2022 | 2022-06-30 | −$92.7M | — | — |
| Q4 2021 | 2021-12-31 | $7.0M | — | — |
MoonLake Immunotherapeutics net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, MoonLake Immunotherapeutics's net debt decreased from $7.0M to −$258.8M, a change of −$265.8M. The latest reported quarter, Q2 2026, shows −$376.4M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MoonLake Immunotherapeutics source filings ↗